All news (page 13)

• 

  16 July 2026

  GS Caltex completes 2026 first-half turnaround at Yeosu Complex using digital and AI

  Nine-unit, ~60-day maintenance used digital and AI tools to speed inspections, clean heater tubes, monitor safety and reinforce safety leadership across operations.
• 

  16 July 2026

  Boehringer Ingelheim: BI 3034701 triple GLP‑1/GIP/NPY2 agonist enters Phase II

  Phase II starts for a potential first‑in‑class triple GLP‑1/GIP/NPY2 receptor agonist targeting weight, satiety and central hunger signalling; study includes dose finding and safety/efficacy evaluation.
• 

  16 July 2026

  Alfen and CATL partner on 5 GWh sodium‑ion storage deployment in Europe

  Joint plan to deploy 5 GWh of sodium‑ion battery storage across Europe to cut costs, diversify supply and reduce exposure to lithium price swings.
• 

  16 July 2026

  Takeda: Zasocitinib achieves high, consistent clearance at hard-to-treat psoriasis sites

  Phase 3 secondary data show ~75% scalp and ~70% palmoplantar clearance at week 16; significant nail improvement; responses sustained to week 24; common AEs: URTI, nasopharyngitis, acne.
• 

  16 July 2026

  Eastman’s Kingsport methanolysis plant hosts EPA officials

  EPA leaders toured a methanolysis unit that processes >250 million lb/yr of polyester waste and reports 20–30% lower GHGs versus fossil-based plastic production.
• 

  16 July 2026

  Infinium supplies eNaphtha for On's CleanCloud EVA midsole

  CO₂‑derived eNaphtha used as a drop‑in feedstock to produce EVA midsoles at commercial scale; shipments began in 2024, ISCC PLUS chain‑of‑custody, and more than one million pairs produced.

• 

  16 July 2026

  MOL: USD 100 million interim insurance payment for Danube Refinery fire

  Insurers admitted liability and will pay USD 100 million as an interim settlement; repairs aim to restore full refinery capacity by end-Q3 2026 after an October 2025 unit fire.
• 

  16 July 2026

  SABIC and Rongsheng sign PDA for Jintang New Materials project in Zhoushan

  Evaluating up to 50% stake in Zhoushan advanced-materials project; PDA sets framework toward a potential FID and joint development.
• 

  16 July 2026

  EIB approves €17.4bn financing package including €800m for Cernavodă and Ukraine border upgrades

  €17.4bn package backs energy projects, an €800m Cernavodă loan, securitisation expansion and upgraded Ukraine–EU crossings.
• 

  16 July 2026

  WISA Group Plc: Finnish regulator approves demerger and listing prospectus; leadership team appointed

  Regulator approved the Finnish-language prospectus for the plywood carve-out; EGM, demerger completion and Nasdaq Helsinki listing set for Aug–Nov 2026.
• 

  16 July 2026

  Gasunie positions the Netherlands as Europe’s CO₂ hub

  Five connected CCS projects (Porthos, Aramis, CO₂next, DRC, DSC) will capture, transport and store CO₂ under the North Sea and link industry across the Netherlands, Belgium and Germany.
• 

  16 July 2026

  Lilly to acquire AtaiBeckley to add rapid-acting neuroplastogen pipeline

  Adds BPL-003 (mebufotenin benzoate intranasal) and VLS-01 (DMT buccal); upfront $6.75/share plus up to $2.50/share CVR tied to development, regulatory and DEA-rescheduling milestones.
• 

  16 July 2026

  Merck’s LIPFENDRA — first FDA‑approved once‑daily oral PCSK9 inhibitor

  Oral macrocyclic peptide enlicitide (20 mg) lowers LDL-C ~56–59% at week 24 in Phase 3 trials; approved as adjunct to diet and exercise for adults with hypercholesterolemia, including HeFH.
• 

  16 July 2026

  Uniper supplies Q1 Energie AG with bio‑LNG

  Initial delivery expands bio‑LNG availability for heavy road transport; biomethane is liquefied at Gate Rotterdam, shipped in ISO tanks to Germany and distributed to filling stations.
• 

  16 July 2026

  BASF inaugurates Düsseldorf emollients plant

  Mid double-digit million-euro investment expands capacity for specialty emollients used in skin care and sun protection, serving European and global cosmetics markets.
• 

  16 July 2026

  Evonik completes backward integration of MetAMINO® network with Mobile methyl mercaptan unit

  On-site methyl mercaptan production is now in Antwerp, Singapore and Mobile, completing integration and trimming DL‑methionine’s carbon footprint by ~7% while cutting hazardous intermediate transport.
• 

  16 July 2026

  Air Liquide invests >160M USD in Arizona for ultra‑pure gases for advanced chips

  Arizona plant to supply ultra-high-purity gases for advanced-chip fab expansion using on-site low-carbon hydrogen production and CO2 capture.
• 

  15 July 2026

  Repsol, Toyota, BMW and Bosch pilot cars on 100% renewable gasoline

  Six-month Spanish trial uses existing cars, 100% renewable gasoline and digital tracking to demonstrate drop-in fuel scalability without new vehicles or infrastructure.
• 

  15 July 2026

  Novo Nordisk wins EU authorisation for Wegovy pill and single‑dose 7.2 mg pen

  OASIS data showed ~17% mean weight loss and ~1 in 3 reached ≥20%; safety comparable to injectable semaglutide; wider roll‑out planned in H2 2026.
• 

  15 July 2026

  PureCycle, Mitsui and RM TOHCELLO to bring recycled PP to BOPP film in Japan

  Aiming to introduce recycled polypropylene into BOPP flexible packaging; pilot runs successful and a commercial agreement is targeted for 2027 ahead of shipments subject to import clearance.
• 

  15 July 2026

  DuPont launches end-to-end Direct Lithium Extraction portfolio

  End-to-end DLE suite of 20+ products across sorbents, membranes and ion-exchange resins, plus lab testing, modeling and piloting to tailor flowsheets to varied brine chemistries.
• 

  15 July 2026

  Merck to present daily, weekly and monthly HIV data at AIDS 2026

  Late‑breakers include Week 48 results for once‑weekly islatravir+lenacapavir and Week 24 data for islatravir+ulonivirine; once‑monthly PrEP trials are enrolling.
• 

  15 July 2026

  GSK completes Nuvalent acquisition, adds three NSCLC assets

  Adds three NSCLC assets including two under FDA review for ROS1 and ALK with target decisions later this year; expected 2026 launches; deal valued at ~$10.6bn.
• 

  15 July 2026

  Johnson & Johnson Q2 2026 results and raises 2026 outlook

  Quarterly sales topped $25.3B; adjusted net earnings and EPS rose, free cash flow improved, and full-year revenue guidance was raised above $100B for the first time.
• 

  15 July 2026

  Merck KEYTRUDA improves PFS vs platinum chemotherapy in dMMR endometrial cancer (Phase 3)

  Phase 3 trial finds pembrolizumab monotherapy improves PFS versus platinum doublet chemotherapy in dMMR advanced or recurrent endometrial cancer.
• 

  15 July 2026

  BASF raises 2026 EBITDA outlook after stronger Q2 results

  Q2 sales rose 16% to €17.2bn; EBITDA before special items €2.4bn; net income lifted by a €3.9bn disposal gain; full-year EBITDA guidance raised to €6.9–7.7bn.
• 

  15 July 2026

  Brenntag and Evonik REXIM: exclusive GMP amino acids distribution across most of Europe

  Exclusive agreement transfers market development and distribution of GMP-grade REXIM amino acids across most of Europe to a regional distributor, effective July 1, 2026.
• 

  15 July 2026

  Axens to build France’s first industrial-scale Jetanol™ SAF unit

  50,000 t/y SAF plant using advanced bioethanol and Jetanol™ technology; production targeted for 2030 to boost French/European SAF supply and meet ReFuelEU targets.
• 

  15 July 2026

  Roche: FDA grants Priority Review for Gazyva/Gazyvaro (obinutuzumab) in primary membranous nephropathy

  Priority Review follows MAJESTY phase III showing 36.9% complete remission at two years vs 5.7% with tacrolimus; FDA decision expected by Nov 2026.
• 

  15 July 2026

  Anglo Asian Mining hires Worley for Xarxar and Garadag copper feasibility studies

  Feasibility studies for two Azerbaijan copper deposits will assess heap‑leach and SX‑EW processing; Xarxar due mid‑2027, Garadag H1 2028; ~90,000 m drilling planned.